Nektar Therapeutics
NKTR
#7606
Rank
โ‚ฌ0.24 B
Marketcap
1,31ย โ‚ฌ
Share price
2.19%
Change (1 day)
210.74%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ0.24 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are โ‚ฌ0.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.24 B-24.66%
2022-12-31โ‚ฌ0.32 B-17.03%
2021-12-31โ‚ฌ0.38 B3.01%
2020-12-31โ‚ฌ0.37 B-26.52%
2019-12-31โ‚ฌ0.51 B35.02%
2018-12-31โ‚ฌ0.37 B7.76%
2017-12-31โ‚ฌ0.35 B-23.22%
2016-12-31โ‚ฌ0.45 B1.53%
2015-12-31โ‚ฌ0.45 B35.09%
2014-12-31โ‚ฌ0.33 B-12.25%
2013-12-31โ‚ฌ0.37 B11.43%
2012-12-31โ‚ฌ0.34 B8.27%
2011-12-31โ‚ฌ0.31 B-2.77%
2010-12-31โ‚ฌ0.32 B-1.98%
2009-12-31โ‚ฌ0.33 B24.65%
2008-12-31โ‚ฌ0.26 B-24.25%
2007-12-31โ‚ฌ0.34 B-14.72%
2006-12-31โ‚ฌ0.41 B-8.64%
2005-12-31โ‚ฌ0.44 B119.36%
2004-12-31โ‚ฌ0.20 B-43.08%
2003-12-31โ‚ฌ0.35 B-6.02%
2002-12-31โ‚ฌ0.38 B-14.89%
2001-12-31โ‚ฌ0.44 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ77.70 B 31,516.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ119.52 B 48,532.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ64.30 B 26,064.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ36.16 M-85.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ60.35 B 24,456.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ17.34 B 6,956.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.80 B 227.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ100.79 B 40,912.95%๐Ÿ‡บ๐Ÿ‡ธ USA